All experiments were conducted on CD8+ T cells that were isolated from HD and HNSCC patients and activated in vitro using anti-CD3 and anti-CD28 antibodies for 72 to 96 h, unless otherwise specified. This evidence concerns the gene CD8A and Huntington disease.